Previous 10 | Next 10 |
Reuters reports that diagnostics gear maker PerkinElmer ( PKI -0.9% ) is the target of a federal inquiry into possible Medicare fraud pertaining to "tens of thousands" of unnecessary genetic cancer tests. More news on: PerkinElmer, Inc., Healthcare stocks news, Stocks on the move, ...
PerkinElmer, Inc. (NYSE: PKI) supports government efforts to identify and prevent abusive practices in healthcare. PerkinElmer has received subpoenas from the government regarding investigations into third parties, and has fully cooperated with authorities and will continue to do so. The Comp...
On Thursday, diagnostic testing company Laboratory Corporation of America (NYSE: LH) launched a new service for businesses through which it will assess employees' health and test them for COVID-19 as part of a return-to-work process. The service can be provided at the employer's...
Executive summary PerkinElmer (NYSE:PKI) is a company that has manufactured analytical, scientific instruments all of its 80 years existence. Yet, over the last 5 years the company has gone through a substantial make-over. This puts the business in the enviable position where today no less...
Image source: The Motley Fool. PerkinElmer Inc (NYSE: PKI) Q1 2020 Earnings Call May 5, 2020 , 5:00 p.m. ET Operator Continue reading
PerkinElmer, Inc. (PKI) Q1 2020 Earnings Conference Call May 05, 2020 5:00 PM ET Company Participants Bryan Kipp - Vice President of Investor Relations Prahlad Singh - President & Chief Executive Officer Jamey Mock - Senior Vice President & Chief Financial Officer Conf...
The following slide deck was published by PerkinElmer, Inc. in conjunction with their 2020 Q1 earnings Read more ...
PerkinElmer (NYSE: PKI ) Q1 results : More news on: PerkinElmer, Inc., Healthcare stocks news, Earnings news and commentary, , Read more ...
PerkinElmer (NYSE: PKI ): Q1 Non-GAAP EPS of $0.67 beats by $0.15 ; GAAP EPS of $0.30 beats by $0.20 . More news on: PerkinElmer, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Revenue of $652.4 million; 1% reported growth; (1)% organic growth GAAP EPS from continuing operations of $0.30; Adjusted EPS of $0.67 Withdrawing previously disseminated FY20 guidance due to COVID-related uncertainties PerkinElmer, Inc. (NYSE: PKI), a global leader c...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...